A comparative effectiveness trial of alternate formats for presenting benefits and harms information for low-value screening services a randomized clinical trial

JAMA Internal Medicine

Volumn 176, Issue 1, 2016, Pages 31-40

  Sheridan, Stacey L ^a,b,c   Sutkowi Hemstreet, Anne ^a,d   Barclay, Colleen ^a   Brewer, Noel T ^a,c   Dolor, Rowena J ^e   Gizlice, Ziya ^a   Lewis, Carmen L ^f   Reuland, Daniel S ^a,b   Golin, Carol E ^a,b,c   Kistler, Christine E ^a,b   Vu, Maihan ^a,c   Harris, Russell ^a,b,c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c University of North Carolina at Chapel Hill   (United States)

^d Napa County Office of Education   (United States)

^e DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; COLORECTAL CANCER; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DECISION SUPPORT SYSTEM; FEMALE; HUMAN; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; OSTEOPOROSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; SCREENING TEST; ADVERSE EFFECTS; ATTITUDE TO HEALTH; BEHAVIOR; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; EARLY CANCER DIAGNOSIS; EVIDENCE BASED MEDICINE; HEALTH SERVICE; MASS SCREENING; MIDDLE AGED; PATIENT EDUCATION; PREVENTION AND CONTROL; PROCEDURES; PROSTATIC NEOPLASMS; RISK ASSESSMENT; SELF CONCEPT; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DECISION SUPPORT TECHNIQUES; EARLY DETECTION OF CANCER; EVIDENCE-BASED MEDICINE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTENTION; MALE; MASS SCREENING; MEDICAL OVERUSE; MIDDLE AGED; OSTEOPOROSIS; PATIENT EDUCATION AS TOPIC; PROSTATIC NEOPLASMS; RISK ASSESSMENT; SELF EFFICACY;

EID: 84954490049     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2015.7339     Document Type: Article

References (50)

1. Harris RP, Wilt TJ, Qaseem A; High Value Care Task Force of the American College of Physicians. A value framework for cancer screening: advice for high-value care from the American College of Physicians. Ann Intern Med. 2015;162(10):712-717.
2. Berwick DM, Hackbarth AD. Eliminating waste in US health care. JAMA. 2012;307(14):1513-1516.
3. Harris RP, Sheridan SL, Lewis CL, et al. The harms of screening: a proposed taxonomy and application to lung cancer screening. JAMA Intern Med. 2014; 174(2):281-285.
4. Davidoff F. On the undiffusion of established practices. JAMA Intern Med. 2015;175(5):809-811.
5. Prasad V, Ioannidis JP. Evidence-based de-implementation for contradicted, unproven, and aspiring healthcare practices. Implement Sci. 2014;9:1.
6. Frieden TR. A framework for public health action: the health impact pyramid. Am J Public Health. 2010;100(4):590-595.
7. Makoul G, Clayman ML. An integrative model of shared decision making in medical encounters. Patient Educ Couns. 2006;60(3):301-312.
8. Berry D, Raynor T, Knapp P, Bersellini E. Over the counter medicines and the need for immediate action: a further evaluation of European Commission recommended wordings for communicating risk. Patient Educ Couns. 2004;53 (2):129-134.
9. Zipkin DA, Umscheid CA, Keating NL, et al. Evidence-based risk communication: a systematic review. Ann Intern Med. 2014;161(4):270-280.
10. Trevena LJ, Zikmund-Fisher BJ, Edwards A, et al. Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers. BMC Med Inform Decis Mak. 2013;13(suppl 2):S7.
11. Bekker HL, Winterbottom AE, Butow P, et al. Do personal stories make patient decision aids more effective? A critical review of theory and evidence. BMC Med Inform Decis Mak. 2013;13(suppl 2):S9.
12. Gallagher KM, Updegraff JA. Health message framing effects on attitudes, intentions, and behavior: a meta-analytic review. Ann Behav med. 2012;43(1):101-116.
13. Shaffer VA, Zikmund-Fisher BJ. All stories are not alike: a purpose-, content-, and valence-based taxonomy of patient narratives in decision aids. Med Decis Making. 2013;33(1):4-13.
14. Sutkowi-Hemstreet A, Vu M, Harris R, Brewer NT, Dolor RJ, Sheridan SL. Adult patients' perspectives on the benefits and harms of overused screening tests: a qualitative study. J Gen Intern Med. 2015;30(11):1618-1626.
15. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(9):627-637.
16. U.S. Preventive Services Task Force. Screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann Intern Med. 2002;137(6):526-528.
17. Moyer VA; U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157(2):120-134.
18. U.S. Preventive Services Task Force. Screening for osteoporosis: U.S. preventive services task force recommendation statement. Ann Intern Med. 2011; 154(5):356-364.
19. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program. http://seer.cancer.gov/. Accessed March 13, 2012.
20. Melton LJ III, Chrischilles EA, Cooper C, Lane AW, Riggs BL. Perspective: how many women have osteoporosis? J Bone Miner Res. 1992;7(9):1005-1010.
21. Neuwirth K, Dunwoody S, Griffin RJ. Protection motivation and risk communication. Risk Anal. 2000;20(5):721-734.
22. Petty RE, Barden J, Wheeler SC. The elaboration likelihood model of persuasion: Health promotions that yield sustained behavioral change. In: DiClemente RJ, Crosby RA, Kegler MC, eds. Emerging Theories in Health Promotion Practice and Research. San Francisco CA: Jossey-Bass; 2002:71-99.
23. Salovey P, Wegner D. Communicating about Health: Message Framing, Persuasion, and Health Behavior. Social Psychological Foundations of Health and Illness. Malden, MA: Blackwell Publishing; 2003:54-81.
24. Sheridan SL, Golin C, Bunton A, et al. Shared decision making for prostate cancer screening: the results of a combined analysis of two practice-based randomized controlled trials. BMC Med Inform Decis Mak. 2012;12:130.
25. Fishbein M. The role of theory in HIV prevention. AIDS Care. 2000;12(3):273-278.
26. Sheeran P. Intention-behavior relations: a conceptual and empirical review. Eur Rev Soc Psychol. 2002;12(1):1-36.
27. Lewis CL, Pignone MP, Sheridan SL, Downs SM, Kinsinger LS. A randomized trial of three videos that differ in the framing of information about mammography in women 40 to 49 years old. J Gen Intern Med. 2003;18(11):875-883.
28. McCormack LA, Bann CM, Williams-Piehota P, et al. Communication message strategies for increasing knowledge about prostate cancer screening. J Cancer Educ. 2009;24(3):238-243.
29. Figueiras MJ, Alves NC. Lay perceptions of serious illnesses: an adapted version of the Revised Illness Perception Questionnaire (IPQ-R) for healthy people. Psychol Health. 2007;22(2):143-158.
30. Schwartz LM, Woloshin S, Black WC, Welch HG. The role of numeracy in understanding the benefit of screening mammography. Ann Intern Med. 1997; 127(11):966-972.
31. Cacioppo JT, Petty RE, Kao CF. The efficient assessment of need for cognition. J Pers Assess. 1984;48(3):306-307.
32. Sheeran P, Orbell S. Augmenting the theory of planned behavior: roles for anticipated regret and descriptive norms. J Appl Soc Psychol. 1999;29(10): 2107-2142.
33. Kellner R, Abbott P, Winslow WW, Pathak D. Fears, beliefs, and attitudes in DSM-III hypochondriasis. J Nerv Ment Dis. 1987;175(1):20-25.
34. Volk RJ, Spann SJ, Cass AR, Hawley ST. Patient education for informed decision making about prostate cancer screening: a randomized controlled trial with 1-year follow-up. Ann Fam Med. 2003;1(1): 22-28.
35. Betsch C, Ulshöfer C, Renkewitz F, Betsch T. The influence of narrative v. statistical information on perceiving vaccination risks. Med Decis Making. 2011;31(5):742-753.
36. Vickers AJ, Altman DG. Statistics notes: analysing controlled trials with baseline and follow up measurements. BMJ. 2001;323(7321):1123-1124.
37. Frison L, Pocock SJ. Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design. Stat Med. 1992;11(13):1685-1704.
38. Stacey D, Bennett CL, Barry MJ, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2011;10 (10):CD001431.
39. Roman BR, Asch DA. Faded promises: the challenge of deadopting low-value care. Ann Intern Med. 2014;161(2):149-150.
40. Ubel PA, Asch DA. Creating value in health by understanding and overcoming resistance to de-innovation. Health Aff (Millwood). 2015;34(2): 239-244.
41. Volk RJ, Hawley ST, Kneuper S, et al. Trials of decision aids for prostate cancer screening: a systematic review. Am J Prev Med. 2007;33(5): 428-434.
42. Colla CH. Swimming against the current: what might work to reduce low-value care? N Engl J Med. 2014;371(14):1280-1283.
43. Lesser LI, Krist AH, Kamerow DB, Bazemore AW. Comparison between US Preventive Services Task Force recommendations and Medicare coverage. Ann Fam Med. 2011;9(1):44-49.
44. Donahue KE, Newton WP, Lefebvre A, Plescia M. Natural history of practice transformation: development and initial testing of an outcomes-based model. Ann Fam Med. 2013;11(3): 212-219.
45. Helfrich CD, Weiner BJ, McKinney MM, Minasian L. Determinants of implementation effectiveness: adapting a framework for complex innovations. Med Care Res Rev. 2007;64(3):279-303.
46. Johnson EJ, Shu SB, Dellaert BG, et al. Beyond nudges: tools of a choice architecture. Mark Lett. 2012;23(2):487-504.
47. Moriates C, Shah N. Creating an effective campaign for change: strategies for teaching value. JAMA Intern Med. 2014;174(10):1693-1695.
48. World Innovation Summit for Health (WISH). Global Diffusion of Healthcare Innovation: Accelerating the Journey. Report of the Global Diffusion of Healthcare Innovation (GDHI) Working Group 2015. http://dpnfts5nbrdps.cloudfront.net/app/media/1744. Accessed July 4, 2015.
49. Hersch J, Barratt A, Jansen J, et al. Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial. Lancet. 2015;385(9978):1642-1652.
50. Sepucha KR, Borkhoff CM, Lally J, et al. Establishing the effectiveness of patient decision aids: key constructs and measurement instruments. BMC Med Inform Decis Mak. 2013;13(suppl 2):S12.